Literature DB >> 10203323

Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice.

R Dantzer1, G Gheusi, R W Johnson, K W Kelley.   

Abstract

To assess the possible modulatory effects of insulin-like growth factor-1 (IGF-1) on the brain effects of proinflammatory cytokines, male CD-1 mice were injected into the lateral ventricle of the brain with a behaviorally depressing dose (100 ng) of the cytokine inducer lipopolysaccharide (LPS) and their response to various doses of IGF-1 (0, 100 and 1000 ng) was measured during behavioral tests carried before and at various time intervals after treatment. LPS induced a profound behavioral depression that was abrogated by the higher dose of IGF-1 tested. Since the behavioral effects of LPS are mediated by the local synthesis and results of proinflammatory cytokines, these results indicate that IGF-1 interferes with the production and/or action of proinflammatory cytokines in the brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203323     DOI: 10.1097/00001756-199902050-00015

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide.

Authors:  Y Huang; C J Henry; R Dantzer; R W Johnson; J P Godbout
Journal:  Neurobiol Aging       Date:  2007-05-31       Impact factor: 4.673

2.  Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand.

Authors:  Ashley M Fenn; Kristen M Smith; Amy E Lovett-Racke; Mireia Guerau-de-Arellano; Caroline C Whitacre; Jonathan P Godbout
Journal:  Neurobiol Aging       Date:  2013-07-21       Impact factor: 4.673

3.  Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice.

Authors:  Rose-Marie Bluthé; Keith W Kelley; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2006-01       Impact factor: 7.217

4.  Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness.

Authors:  Daniel R Johnson; Jason C O'Connor; Robert Dantzer; Gregory G Freund
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

5.  A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide.

Authors:  H D Venters; Q Tang; Q Liu; R W VanHoy; R Dantzer; K W Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

6.  Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures.

Authors:  Xin Fu; Samantha M Zunich; Jason C O'Connor; Annemieke Kavelaars; Robert Dantzer; Keith W Kelley
Journal:  J Neuroinflammation       Date:  2010-08-02       Impact factor: 8.322

Review 7.  From inflammation to sickness and depression: when the immune system subjugates the brain.

Authors:  Robert Dantzer; Jason C O'Connor; Gregory G Freund; Rodney W Johnson; Keith W Kelley
Journal:  Nat Rev Neurosci       Date:  2008-01       Impact factor: 34.870

8.  TNFalpha-induced sickness behavior in mice with functional 55 kD TNF receptors is blocked by central IGF-I.

Authors:  Karine Palin; Rose-Marie Bluthé; Robert H McCusker; Françoise Moos; Robert Dantzer; Keith W Kelley
Journal:  J Neuroimmunol       Date:  2007-05-18       Impact factor: 3.478

Review 9.  Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology.

Authors:  Jason C O'Connor; Robert H McCusker; Klemen Strle; Rodney W Johnson; Robert Dantzer; Keith W Kelley
Journal:  Cell Immunol       Date:  2008-03-05       Impact factor: 4.868

10.  Taking the Perspective that a Depressive State Reflects Inflammation: Implications for the Use of Antidepressants.

Authors:  Jill Leslie Littrell
Journal:  Front Psychol       Date:  2012-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.